BERLIN--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by ...
The grant program run by the German Federal Ministry of Education and Research (BMBF) supports SMEs working on innovative projects in biomedicine Non-dilutive support for planned phase 2 trial now ...
Live Science on MSN
It matters what time of day you get cancer treatment, study suggests
Giving immunotherapy earlier in the day can significantly extend patients' survival, compared to giving treatment later in the day, a new study of lung cancer shows.
Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback